Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2009-09-30
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laser treatment with Purpuric settings
Pulsed dye laser treatment at purpuric settings with pulse duration of 1.5msec.
Laser treatment with Nonpurpuric settings
Pulsed dye laser treatment with nonpurpuric settings with pulse duration 10msec.
No treatment
No laser treatment
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing to participate.
* Able to give informed consent
Exclusion Criteria
* Fitzpatrick skin type V or VI.
* Prior history of known light sensitivity.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Diego
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Julie Akiko Gladsjo
Clinical Instructor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julie A Gladsjo, MD PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Diego
S. Brian Jiang, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Diego
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCSD Perlman Ambulatory Center - Dermatology clinic
La Jolla, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
090690
Identifier Type: -
Identifier Source: org_study_id